Vaseline Eczema Calming Therapy Cream Recalled for Storage Temperature Violations
Family Dollar Stores is recalling Vaseline Eczema Calming Therapy Cream (6.8 oz) distributed nationwide from April 30 to June 10, 2022, because the product was held outside appropriate storage temperature conditions in violation of CGMP requirements.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II indicates potential health consequences, but the specific hazard—storage temperature deviation affecting product quality—is precautionary with no reported illnesses or injuries, fitting the Moderate severity category.
Plain-English summary
Family Dollar Stores, Llc. is recalling Vaseline Eczema Calming Therapy Cream (6.8 oz, SKU 2098741) that was distributed to specific Family Dollar Stores nationwide between April 30, 2022, and June 10, 2022.
The recall was initiated due to CGMP (Current Good Manufacturing Practice) deviations: the product was held outside appropriate storage temperature conditions.
Consumers who purchased this product from Family Dollar Stores during the specified distribution period should discontinue use and contact the company for further information.
The recalled product
- Product
- VASELINE ECZEMA CALMING THERPY CRM 6.8 OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Topical cream
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 2098741
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27